ITGAX and neoplasm: This increase in the percentage of lysis was reflected in an increase in tumor cell uptake by DCs (% of CFSE+ cells within the CD11c+ DCs), which reached the highest level when both NK cells and Cetuximab were present (Figure 1, right panel).